May 19, 2011

Consortium Will Further Reduce HIV Drug Pricing in Developing World

The Clinton Health Access Initiative (CHAI), UNITAID and the U.K. Department for International Development (DFID) will further reduce HIV drug pricing in the developing world, according to a UNITAID statement. CHAI’s Procurement Consortium reaches over 70 countries and supplies 70 percent of people living with HIV in these regions with negotiated pricing for preferred first-line treatment options, such as meds containing tenofovir and efavirenz.

To read the UNITAID statement, click here.

Search: Clinton Health Access Initiative, CHAI, UNITAID and the U.K. Department for International Development, DFID, tenofovir, efavirenz

Scroll down to comment on this story.